Theme 10 - Disease Stratification and Phenotyping of Patients
2023; Taylor & Francis; Volume: 24; Issue: sup1 Linguagem: Inglês
10.1080/21678421.2023.2260202
ISSN2167-9223
Tópico(s)Neurological diseases and metabolism
ResumoAcknowledgmentsWe would like to acknowledge the Macquarie University Neurodegenerative Disease Biobank for provision of patient samples and related clinical data.AcknowledgementsWe thank the pALS who participated in VITALITY-ALS and their families for their contributions to the trial.AcknowledgementsWe would like to thank patients for taking part in the study.AcknowledgementsWe are grateful to the families who contributed with their time on partaking in our study.AcknowledgementsHealth Research Board, Research Motor Neurone (www.mnd.ie). Thanks to participants.AcknowledgementsWe thank all individuals who took part in the study and MND and Me, FightMND, The Honda Foundation, and Wesley Medical Research for funding support.AcknowledgmentsWe wish to acknowledge all individuals who contributed measures of activity.AcknowledgementsThank you to all patients, family members, and staff involved in the collection of the ALS Biomarkers Study data.AcknowledgmentsThe authors thank Irene Brody, VMD, PhD of p-value communications, Cedar Knolls, NJ, USA, for providing medical writing support. Editorial support was also provided by p-value communications.
Referência(s)